An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMC 3547667)

Published in Cancer Cell on November 13, 2012

Authors

Tanja A Gruber1, Amanda Larson Gedman, Jinghui Zhang, Cary S Koss, Suresh Marada, Huy Q Ta, Shann-Ching Chen, Xiaoping Su, Stacey K Ogden, Jinjun Dang, Gang Wu, Vedant Gupta, Anna K Andersson, Stanley Pounds, Lei Shi, John Easton, Michael I Barbato, Heather L Mulder, Jayanthi Manne, Jianmin Wang, Michael Rusch, Swati Ranade, Ramapriya Ganti, Matthew Parker, Jing Ma, Ina Radtke, Li Ding, Giovanni Cazzaniga, Andrea Biondi, Steven M Kornblau, Farhad Ravandi, Hagop Kantarjian, Stephen D Nimer, Konstanze Döhner, Hartmut Döhner, Timothy J Ley, Paola Ballerini, Sheila Shurtleff, Daisuke Tomizawa, Souichi Adachi, Yasuhide Hayashi, Akio Tawa, Lee-Yung Shih, Der-Cherng Liang, Jeffrey E Rubnitz, Ching-Hon Pui, Elaine R Mardis, Richard K Wilson, James R Downing

Author Affiliations

1: Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Articles citing this

Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer (2013) 1.67

The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet (2013) 1.31

The aurora kinases in cell cycle and leukemia. Oncogene (2014) 1.20

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms. Cancer Discov (2015) 1.17

Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood (2015) 1.16

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood (2016) 1.05

miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget (2015) 1.00

Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. J Clin Oncol (2015) 1.00

Toward an evolutionary model of cancer: Considering the mechanisms that govern the fate of somatic mutations. Proc Natl Acad Sci U S A (2015) 0.99

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study. Blood (2015) 0.92

PAX5 is a tumor suppressor in mouse mutagenesis models of acute lymphoblastic leukemia. Blood (2015) 0.91

Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia. PLoS One (2014) 0.88

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia. PLoS Genet (2015) 0.87

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study. Blood (2016) 0.87

AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL. Leukemia (2013) 0.87

DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia. Oncotarget (2013) 0.86

The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment. Ann N Y Acad Sci (2014) 0.85

Structural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectives. Oncotarget (2015) 0.85

The biology of pediatric acute megakaryoblastic leukemia. Blood (2015) 0.84

The most informative spacing test effectively discovers biologically relevant outliers or multiple modes in expression. Bioinformatics (2014) 0.84

Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7. J Biol Chem (2014) 0.84

Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia. Clin Cancer Res (2013) 0.84

Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia. Oncol Rep (2013) 0.81

Control of developmentally primed erythroid genes by combinatorial co-repressor actions. Nat Commun (2015) 0.80

Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial. Ann Hematol (2015) 0.80

Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations. Genome Med (2016) 0.79

Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group. Leukemia (2016) 0.79

Directional genomic hybridization for chromosomal inversion discovery and detection. Chromosome Res (2013) 0.79

Human inversions and their functional consequences. Brief Funct Genomics (2015) 0.78

Epigenetic regulators and their impact on therapy in acute myeloid leukemia. Haematologica (2016) 0.78

Pancreatic cancer patient survival correlates with DNA methylation of pancreas development genes. PLoS One (2015) 0.77

Functional screen identifies regulators of murine hematopoietic stem cell repopulation. J Exp Med (2016) 0.77

Infants with acute myeloid leukemia treated according to the Associazione Italiana di Ematologia e Oncologia Pediatrica 2002/01 protocol have an outcome comparable to that of older children. Haematologica (2014) 0.77

Baicalein antagonizes acute megakaryoblastic leukemia in vitro and in vivo by inducing cell cycle arrest. Cell Biosci (2016) 0.77

AMKL chimeric transcription factors are potent inducers of leukemia. Leukemia (2017) 0.76

BMP meets AML: induction of BMP signaling by a novel fusion gene promotes pediatric acute leukemia. Cancer Cell (2012) 0.76

Whole-exome sequencing identifies a novel somatic mutation in MMP8 associated with a t(1;22)-acute megakaryoblastic leukemia. Leukemia (2013) 0.75

MN1-Fli1 oncofusion transforms murine hematopoietic progenitor cells into acute megakaryoblastic leukemia cells. Oncogenesis (2015) 0.75

A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy. Oncotarget (2014) 0.75

The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. Stem Cell Reports (2015) 0.75

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene. J Hematol Oncol (2017) 0.75

Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes. Nat Genet (2017) 0.75

Tales from the Jazz ASH: highlights from the 2013 American Society of Haematology meeting. Ecancermedicalscience (2014) 0.75

Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene. Turk J Haematol (2016) 0.75

Articles cited by this

Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19

Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91

Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52

Detection of large-scale variation in the human genome. Nat Genet (2004) 49.18

Circos: an information aesthetic for comparative genomics. Genome Res (2009) 40.02

Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78

Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (2004) 24.18

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80

Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61

Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68

Hedgehog signaling in animal development: paradigms and principles. Genes Dev (2001) 14.75

An optimized transgenesis system for Drosophila using germ-line-specific phiC31 integrases. Proc Natl Acad Sci U S A (2007) 12.13

SNPdetector: a software tool for sensitive and accurate SNP detection. PLoS Comput Biol (2005) 10.04

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89

Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol (2007) 8.08

A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res (1995) 7.08

Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics (2004) 6.78

Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem (2001) 5.89

CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods (2011) 5.34

A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development (1997) 5.09

A flexible and efficient template format for circular consensus sequencing and SNP detection. Nucleic Acids Res (2010) 4.48

Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol (2001) 3.97

Hox genes in hematopoiesis and leukemogenesis. Oncogene (2007) 3.55

Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell (2002) 3.41

Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature (2009) 3.13

Gli proteins in development and disease. Annu Rev Cell Dev Biol (2011) 3.04

Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood (2000) 2.65

Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development (2007) 2.60

Morphogens, their identification and regulation. Development (2004) 2.58

Interdigital regulation of digit identity and homeotic transformation by modulated BMP signaling. Science (2000) 2.56

Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet (2001) 2.55

The Pediatric Cancer Genome Project. Nat Genet (2012) 2.49

Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet (2007) 2.46

Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci U S A (2001) 2.35

The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line. Mol Cell Biol (1995) 2.08

Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci U S A (2009) 1.92

Reference alignment of SNP microarray signals for copy number analysis of tumors. Bioinformatics (2008) 1.91

Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer. Trends Mol Med (2010) 1.82

Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med (1999) 1.71

The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8(ETO) family. Blood (1998) 1.64

Activating mutations in human acute megakaryoblastic leukemia. Blood (2008) 1.56

AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia (2005) 1.51

Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood (2001) 1.50

The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation. Science (2011) 1.49

Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling. Ann N Y Acad Sci (2009) 1.45

Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice. Int J Hematol (2001) 1.32

Deletion of Mtg16, a target of t(16;21), alters hematopoietic progenitor cell proliferation and lineage allocation. Mol Cell Biol (2008) 1.29

Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex. Cancer Cell (2011) 1.25

The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. Blood (1991) 1.23

The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity. Mol Cell Biol (2000) 1.18

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer (2007) 1.18

Identification of NKL, a novel Gli-Kruppel zinc-finger protein that promotes neuronal differentiation. Development (2001) 1.17

BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood (2008) 1.10

Adult acute megakaryocytic leukemia: an analysis of 37 patients treated at M.D. Anderson Cancer Center. Blood (2005) 1.06

Gli-similar (Glis) Krüppel-like zinc finger proteins: insights into their physiological functions and critical roles in neonatal diabetes and cystic renal disease. Histol Histopathol (2010) 1.04

The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood (1992) 1.04

Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol (1989) 1.03

The extracellular loops of Smoothened play a regulatory role in control of Hedgehog pathway activation. Development (2012) 1.01

The Krüppel-like zinc finger protein Glis2 functions as a negative modulator of the Wnt/beta-catenin signaling pathway. FEBS Lett (2007) 0.96

Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia. Blood (2009) 0.94

Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4. Blood Cells Mol Dis (2002) 0.89

Spalt major controls the development of the notum and of wing hinge primordia of the Drosophila melanogaster wing imaginal disc. Dev Biol (2009) 0.88

Drosophila Smad2 opposes Mad signaling during wing vein development. PLoS One (2010) 0.84

Hedgehog signaling in hematopoiesis. Crit Rev Eukaryot Gene Expr (2010) 0.83

Functional characterization of two promoters in the human bone morphogenetic protein-4 gene. J Bone Miner Res (1999) 0.83

Articles by these authors

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35

Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res (2005) 44.08

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13

Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09

Whole-genome sequencing and variant discovery in C. elegans. Nat Methods (2008) 31.92

Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med (2006) 22.86

Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med (2002) 20.68

International network of cancer genome projects. Nature (2010) 20.35

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood (2008) 20.32

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68

The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73

BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41

Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol (2003) 17.67

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med (2003) 17.23

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12

VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics (2009) 16.04

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90

Extending assembly of short DNA sequences to handle error. Bioinformatics (2007) 14.46

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33

Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29

DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07

Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med (2006) 13.54

The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol (2003) 13.32

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med (2008) 13.02

Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55

The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature (2003) 12.44

PCAP: a whole-genome assembly program. Genome Res (2003) 12.36

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell (2002) 11.83

Frequent pathway mutations of splicing machinery in myelodysplasia. Nature (2011) 11.44

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med (2003) 11.17

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54

BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature (2008) 10.12

Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med (2011) 9.90

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89